elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26771762-0373D166-E563-423F-96FA-C082CA089EBD
Q26771762-0373D166-E563-423F-96FA-C082CA089EBD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26771762-0373D166-E563-423F-96FA-C082CA089EBD
New Therapeutic Options for Autism Spectrum Disorder: Experimental Evidences
P2860
Q26771762-0373D166-E563-423F-96FA-C082CA089EBD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26771762-0373D166-E563-423F-96FA-C082CA089EBD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e682e6a4cff592c795dac99d0ff27332f3a455c2
P2860
Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study.